Serum exosomal miR-122-5p is a new biomarker for both acute coronary syndrome and underlying coronary artery stenosis.

Conclusion: Serum exosomal miR-122-5p might be useful as a diagnostic biomarker for AMI and UA, and increased serum exosomal miR-122-5p levels could be useful to predict the severity of coronary lesions.
PMID: 32723190 [PubMed - as supplied by publisher]

Source: Biomarkers - July 31, 2020 Category: Research Tags: Biomarkers Source Type: research